Suppr超能文献

全球范围内对COVID-19疫苗及加强针的犹豫态度:一项文献综述

COVID-19 vaccine and booster hesitation around the world: A literature review.

作者信息

Shah Aashka, Coiado Olivia C

机构信息

Carle Illinois College of Medicine, University of Illinois at Urbana-Champaign, Urbana, IL, United States.

Department of Biomedical and Translational Sciences, University of Illinois at Urbana-Champaign, Urbana, IL, United States.

出版信息

Front Med (Lausanne). 2023 Jan 12;9:1054557. doi: 10.3389/fmed.2022.1054557. eCollection 2022.

Abstract

The development of COVID-19 vaccines has helped limit the extent of the pandemic, which over the past 2 years has claimed the lived of millions of people. The Moderna and Pfizer COVID-19 vaccines were the first to be manufactured using mRNA technology. Since then, other manufacturers have built their own vaccines which utilize adenovirus vector, whole inactivated coronavirus, and protein subunit methods. Given the continued mutation of the SARS-CoV-2 virus, a booster of the COVID-19 vaccine offers additional protection for citizens, especially those with comorbid conditions. However, uptake of the vaccine and booster has faced hurdles. This literature review aims to analyze the acceptance of the COVID-19 booster among different populations throughout the world. Keywords searched include "COVID-19 vaccine rates OR COVID-19 booster rates," "COVID-19 vaccine hesitancy," "COVID-19 booster hesitancy," "reasons against COVID-19 vaccine," "reasons for COVID-19 vaccine," and "COVID-19 vaccine acceptance" (for each country). Research articles indexed in PubMed, University of Illinois Urbana-Champaign Library, and Google Scholar were included. Despite the proven effectiveness of the COVID-19 booster, vaccine hesitancy is still causing suboptimal compliance to the primary vaccine and booster, thus slowing down control of the pandemic. Reasons for vaccine hesitancy differ by country and acceptance is affected by misinformation, political circumstances, and cultural values. Among the most common reasons found are distrust in the government, a lack of safety information, and fear of side effects. Uptake of the COVID-19 vaccine has also been delayed in low and middle income countries due to resource allocation and as a result, these countries have fallen behind vaccination benchmarks. The future of COVID-19 vaccination is unknown, but vaccine mandates and additional booster doses are a possibility. Determining the ethical impact that these policies could have will allow for the best implementation.

摘要

新冠疫苗的研发有助于限制疫情的蔓延程度,在过去两年里,这场疫情已夺走数百万人的生命。莫德纳和辉瑞的新冠疫苗是首批采用信使核糖核酸(mRNA)技术生产的疫苗。从那时起,其他制造商也研发出了各自的疫苗,这些疫苗采用了腺病毒载体、全灭活冠状病毒和蛋白质亚基方法。鉴于严重急性呼吸综合征冠状病毒2(SARS-CoV-2)病毒的持续变异,新冠疫苗加强针为公民提供了额外的保护,尤其是那些患有合并症的人。然而,疫苗和加强针的接种面临着障碍。这篇文献综述旨在分析全球不同人群对新冠疫苗加强针的接受情况。搜索的关键词包括“新冠疫苗接种率或新冠疫苗加强针接种率”、“新冠疫苗犹豫”、“新冠疫苗加强针犹豫”、“反对接种新冠疫苗的原因”、“接种新冠疫苗的原因”以及“(针对每个国家的)新冠疫苗接受情况”。纳入了在PubMed、伊利诺伊大学厄巴纳-香槟分校图书馆和谷歌学术上索引的研究文章。尽管新冠疫苗加强针已被证明有效,但疫苗犹豫仍导致对初级疫苗和加强针的接种率未达最佳水平,从而减缓了疫情的控制。疫苗犹豫的原因因国家而异,接受程度受到错误信息、政治环境和文化价值观影响。其中最常见的原因包括对政府的不信任、缺乏安全信息以及对副作用的恐惧。由于资源分配问题,低收入和中等收入国家的新冠疫苗接种也被推迟,结果这些国家未能达到疫苗接种基准。新冠疫苗接种的未来尚不明朗,但疫苗强制令和额外的加强针剂量是有可能的。确定这些政策可能产生的伦理影响将有助于实现最佳实施。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/586b/9878297/6f6d7899ce9c/fmed-09-1054557-g0001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验